题名 | The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials |
作者 | |
发表日期 | 2021-06 |
发表期刊 | PHYTOTHERAPY RESEARCH 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Review |
关键词 | Tripterygium wilfordii glycosides rheumatoid arthritis meta‐ analysis RCT systematic review |
其他关键词 | HOOK-F ; METHOTREXATE ; GUIDELINES ; ANTICANCER ; EXTRACT ; HERB |
摘要 | Objective This systematic review and meta-analysis were performed to investigate the efficacy and safety of Tripterygium wilfordii glycosides (TG) for rheumatoid arthritis (RA) from the current literature. Methods An electronic search was conducted in eight databases (PubMed, EMBASE, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database, Chinese VIP Database, and Wanfang Database) from inception until September 2020. Randomized controlled trials (RCTs) with risk of bias (RoB) score >= 4 according to the Cochrane RoB tool were included for the analyses. The primary outcome measures were duration of morning stiffness (DMS), tender joint count (TJC), swollen joint count (SJC), visual analog score (VAS), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF). The secondary outcome measures were the total clinical effective rate and adverse events. All the analyses were used by the random effects models. The meta-analysis was performed using RevMan 5.3 and STATA 14.0. Results A total of 40 RCTs with 3092 patients met our inclusion criteria. This meta-analysis showed that TG plus DMARDs for RA could decrease the DMS (p < .001), TJC (p < .001), SJC (p < .001), VAS (p < .001), serum CRP (p < .001), ESR (p < .001), and RF (p < .001) and improve total effective rate (p < .001). In addition, TG was generally safe and well tolerated in RA patients. Conclusion Despite the limitations, the present evidence supports, at least to an extent, that TG can be recommended for routine use for RA patients. More large multicenter and high-quality RCTs are required for further research. |
出版者 | WILEY |
出版地 | HOBOKEN |
ISSN | 0951-418X |
EISSN | 1099-1573 |
卷号 | 35期号:6页码:2902-2924 |
DOI | 10.1002/ptr.6996 |
页数 | 23 |
WOS类目 | Chemistry, Medicinal ; Pharmacology & Pharmacy |
WOS研究方向 | Pharmacology & Pharmacy |
WOS记录号 | WOS:000601214300001 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 33368709 |
SCOPUSEID | 2-s2.0-85099517029 |
通讯作者地址 | [Chen, Hua]Department of Orthopaedic Surgery,The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,China |
Scopus学科分类 | Pharmacology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/14635 |
专题 | 第二临床医学院,附属第二医院、育英儿童医院 |
通讯作者 | Chen, Hua |
作者单位 | 1.Department of Orthopaedic Surgery,The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,China; 2.Department of Emergency,The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,China |
第一作者单位 | 第二临床医学院,附属第二医院、育英儿童医院 |
通讯作者单位 | 第二临床医学院,附属第二医院、育英儿童医院 |
第一作者的第一单位 | 第二临床医学院,附属第二医院、育英儿童医院 |
推荐引用方式 GB/T 7714 | Zheng, Wenhao,Mei, Yifan,Chen, Chunhui,et al. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials[J]. PHYTOTHERAPY RESEARCH,2021,35(6):2902-2924. |
APA | Zheng, Wenhao, Mei, Yifan, Chen, Chunhui, Cai, Leyi, & Chen, Hua. (2021). The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials. PHYTOTHERAPY RESEARCH, 35(6), 2902-2924. |
MLA | Zheng, Wenhao,et al."The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials".PHYTOTHERAPY RESEARCH 35.6(2021):2902-2924. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论